| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/04/2005 | CN1611240A Fresh ginger soft capsule and its preparing method |
| 05/04/2005 | CN1611239A Ginger tablet and its preparing method |
| 05/04/2005 | CN1611236A Chinese medicine composition for treating hepatitis and its preparing method |
| 05/04/2005 | CN1611224A Compound preparation of notoginseng total saponin and quzaqi aglycone and its preparing method |
| 05/04/2005 | CN1611221A Injection liquid containing alprostadic and its production process |
| 05/04/2005 | CN1611215A Pharmaceutical use of dihydro myricetin |
| 05/04/2005 | CN1611213A Novel 13 uses of neoarsphenamine |
| 05/04/2005 | CN1200106C Dual-plasmid gene vaccine resisting against hepatitis B virus, and its preparing process and application |
| 05/04/2005 | CN1200097C Recombinant human epidermal growth factor and its preparing process and medicinal composition |
| 05/04/2005 | CN1200090C Ostrica bone medicinal liquor and preparation method thereof |
| 05/04/2005 | CN1200000C Cyclie somatostatin analogs |
| 05/04/2005 | CN1199987C Basic monocyclic compounds having NK2 antagonist action, processes for their preparation and formulations containing them |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199684C Chinese medicine for treating hepatitis B and process for preparing same |
| 05/04/2005 | CN1199680C Healthy food for loosting bowel to relieve constipation |
| 05/04/2005 | CN1199679C Medicine for nourishing yin and fortifying kidney, benefiting qi and fortifying spleen, and its preparation method |
| 05/04/2005 | CN1199678C Medicament for curing lithiasis |
| 05/04/2005 | CN1199671C Improved process for preparing Chinese medicine capsule for treating constipation |
| 05/04/2005 | CN1199666C Powdered medicine for treating intractable ulcer |
| 05/04/2005 | CN1199663C Medicine for treating stomach disease and its preparation method |
| 05/04/2005 | CN1199662C Medicine for curing peptic ulcer and its preparation method |
| 05/04/2005 | CN1199655C 'Ruwei' powder medicine for gastroenteric diseases |
| 05/04/2005 | CN1199638C Adaptation of anethoe trithione for use in prepn. of medicine |
| 05/04/2005 | CN1199636C Use of 15-deoxysperguallin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887894 Use of lipoic acid for improving the bioavailability of mineral salts |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887884 For therapy of neurological and psychological disorders |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887465 Combined with ingestable support comprising milk, yogurt, curd, fermented milks, cereals, powders, and/or infant formula; prevents intestinal colonization and infection of epithelial cells |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 05/03/2005 | CA2193994C Process for synthesis of substituted sulphoxides |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/28/2005 | WO2005037188A2 Therapeutic agent for periodontal disease |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2005014032B1 Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090661 For use as heat shock protein expression promoter, cell injury/death inhibitor, and cell and tissue protecting agent (organ preservation agent), antiulcer agent, antihepatopathic agent, and interleukin production promoter |
| 04/28/2005 | US20050090556 Method for treatment of external secretion disorders |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090516 Novel substituted imides |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090473 Formulations and methods of treating inflammatory bowel disease |
| 04/28/2005 | US20050090457 Method of treating mammals with genistein and/or genistein analogues |
| 04/28/2005 | US20050090000 Novel human 7TM protein and polynucleotides encoding the same |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089586 Extract of acanthopanax koreanum for the treatment or prevention of hepatitis or the liver protective drug |
| 04/28/2005 | US20050089571 Pharmaceutical formulation for the active ingredient budesonide |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089495 Transdermal transport of compounds |
| 04/28/2005 | US20050087198 Method for systemic drug delivery through the nail |
| 04/28/2005 | CA2543447A1 Antibody and use of the same |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/28/2005 | CA2541857A1 Combination therapy for hcv infection |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1525886A1 Absorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525882A1 Administration form comprising an acid-labile active compound |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525198A2 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1524912A1 Compositions comprising lactoferrin |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1357910B1 Method for preventing and treating visceral pain and gastrointestinal disorders |